Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axomadol dose escalation in healthy recreational opiate users
NCT03765658Phase 1Completed
- Sponsor
- Grünenthal GmbH
- Start
- Jan 2006
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of axomadol in pain, sponsored by Grünenthal GmbH. Primary endpoint: Maximum Tolerated Dose. Started Jan 2006; status: completed.
02
Drugs
axomadol
03
Conditions
pain
Beyond the preview
Go deeper on NCT03765658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03765658.